C07D - Heterocyclic compounds

More topics under "C07D - Heterocyclic compounds" (1,537,440)
C07D 201 - Preparation, separation, purification, or stabilisation of unsubstituted lactams (2,192)
C07D 203 - Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom (1,097)
C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom (1,649)
C07D 227 - Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups (473)
C07D 229 - Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms (515)
C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
C07D 245 - Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms (898)
C07D 247 - Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups (239)
C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
C07D 251 - Heterocyclic compounds containing 1,3,5-triazine rings (10,913)
C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
C07D 255 - Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups (739)
C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
C07D 259 - Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms (488)
C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022)
C07D 269 - Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups (111)
C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
C07D 273 - Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups (2,368)
C07D 275 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings (4,972)
C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
C07D 283 - Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups (102)
C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
C07D 291 - Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms (1,087)
C07D 293 - Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms (553)
C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
C07D 301 - Preparation of oxiranes (10,136)
C07D 303 - Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom (12,512)
C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
C07D 315 - Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups (1,360)
C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
C07D 323 - Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms (1,581)
C07D 325 - Heterocyclic compounds containing rings having oxygen as the only ring hetero atom according to more than one of groups (168)
C07D 327 - Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms (2,428)
C07D 329 - Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms (47)
C07D 331 - Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom (456)
C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
C07D 337 - Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom (875)
C07D 339 - Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms (3,352)
C07D 341 - Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms (281)
C07D 343 - Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms (52)
C07D 345 - Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms (419)
C07D 347 - Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms (38)
C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
C07D 415 - Heterocyclic compounds containing the thiamine skeleton (90)
C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
C07D 419 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms (1,431)
C07D 421 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms (480)
C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
C07D 455 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine (2,122)
C07D 457 - Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid (836)
C07D 459 - Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone (97)
C07D 461 - Heterocyclic compounds containing indolo [3, 2, 1-d, e] pyrido [3, 2, 1-i, j] [1, 5]-naphthyridine ring systems, e.g. vincamine (286)
C07D 463 - Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (613)
C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718)
C07D 477 - Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (2,484)
C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334)
C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
C07D 497 - Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms (1,069)
C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
C07D 499 - Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (3,448)
C07D 501 - Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (7,574)
C07D 503 - Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (648)
C07D 505 - Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (556)
C07D 507 - Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by groups , or; Such ring systems being further condensed (161)
C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
C07D 515 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (877)
C07D 517 - Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms (452)
C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)

Patents for C07D - Heterocyclic compounds (10,420)
06/2006
06/29/2006	US20060142277 Substituted aralkyl derivatives
06/29/2006	US20060142269 New compounds
06/28/2006	EP1674102A1 Use of flibanserin in the treatment of sexual disorders
06/28/2006	EP1673369A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
06/28/2006	EP1673339A2 Heterocyclic inhibitors of mek and methods of use thereof
06/28/2006	CN1795174A Novel substituted 3-sulfur indoles
06/28/2006	CN1261163C Stabilization of macrolides
06/27/2006	US7067667 Aminoalkyl-3, 4-dihydroquinoline derivatives as no-synthase inhibitors
06/27/2006	US7067663 Triazolo pyrimidine compounds
06/27/2006	US7067513 Phenylpiperazines
06/27/2006	US7067501 Phenylsulfanylphenyl and phenyloxyphenyl substituted piperazine compounds; glycine transport inhibitors; for the treatment of psychoses and convulsive disorders: epilepsy, spasticity, and myoclonus
06/27/2006	CA2408909C Azabicyclo[3.2.1]octane triazolyl tropane derivatives as ccrs5 modulators
06/22/2006	WO2006065216A1 Novel hydantoin derivatives as metalloproteinase inhibitors
06/22/2006	WO2006065215A1 Novel compounds
06/22/2006	WO2006064221A1 Process for the preparation of n- (4-piperidinyl) -n-ethyl-phenylacetamides from n-boc-4-oxopiperidine
06/22/2006	US20060135517 Imidazolopyridines and methods of making and using the same
06/22/2006	US20060135398 Crystalline modification
06/22/2006	CA2590845A1 Novel hydantoin derivatives as metalloproteinase inhibitors
06/22/2006	CA2590843A1 Novel hydantoin derivatives as metalloproteinase inhibitors
06/21/2006	EP1671960A2 Process for selective derivatization of taxanes
06/21/2006	EP1671949A2 Substituted phenylamines and pyridinylamines
06/21/2006	EP1670802A2 Novel heterocyclic compounds as hsp90-inhibitors
06/21/2006	EP1670790A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
06/21/2006	EP1670787A2 Cytokine inhibitors
06/21/2006	EP1670770A1 Benzimidazole derivatives, compositions containing them, preparation therof and uses thereof
06/21/2006	EP1670769A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
06/21/2006	EP1670511A2 Cripto antagonism of activin and tgf-b signaling
06/21/2006	EP1670478A2 Heteroaromatic selective inhibitors of neuronal nitric oxide synthase
06/21/2006	EP1670474A2 Cyclic pyrazinoylguanidine sodium channel blockers
06/21/2006	EP1244647B1 Quinazoline derivatives as vegf inhibitors
06/21/2006	EP1123278B1 Method for producing (+)-exo-6-phenyl-3-azabicyclo- 3.2.0\|heptanes
06/21/2006	CN1791885A An enhanced system for electronic funds transfer and elimination of the payee's need for encryption and privacy
06/21/2006	CN1791578A Diarylmethylidene piperidine derivatives and their use as delta opioid receptor agonists
06/21/2006	CN1791401A Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof
06/21/2006	CN1789264A Crystals including a malic acid salt of a 3-pyrrole substituted 2-indolinone, and compositions thereof
06/21/2006	CN1260227C 5-membered ring heterocyclic compounds with nitrogen
06/20/2006	US7064212 Dicationic viologens, such as methyl viologen and benzyl viologen, associated with anions selected from bis(trifluoro-methyl(or perfluoroethyl)sulfonyl)imide and tris(trifluoro-methylsulfonyl)methide; soluble in quat ammonium melts
06/20/2006	US7064126 Compounds
06/15/2006	US20060128963 Piperidine derivatives as melanocortin-4 receptor agonists
06/15/2006	US20060128697 Disease associated with AMPA (alpha -amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid) flux; cognitive disorders, anxiety or depressive syndromes, neurodegenerative diseases; N-(2-{4-[(5,5-dioxido-2,3,3a,4-tetrahydro-1H-pyrrolo[2,1-c][1,2,4]benzothiadiazin-7-yl)oxy]phenyl}ethyl)methanesulphonamide
06/15/2006	US20060127423 Organic compounds
06/14/2006	EP1669072A1 Benzothiazine and benzothiadiazine derivatives, process for their preparation and phamaceutical compositions containing them
06/14/2006	EP1667990A2 New compounds
06/14/2006	EP1667965A2 Bridged macrocyclic module compositions
06/14/2006	CN1788007A Crystal of benzimidazole derivative and process for producing the same
06/14/2006	CN1785982A New benzothiazine and benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them
06/13/2006	US7060864 Toluene methylation process
06/13/2006	CA2433288C Process for making amlodipine maleate
06/10/2006	CA2527585A1 New benzothiazine and benzothiadiazine derivatives, their preparation process and the pharmaceutical compounds that contain them
06/08/2006	WO2006059945A1 Novel compounds
06/08/2006	WO2005009953A3 Crystalline substance with tailored angle between surfaces
06/08/2006	WO2004072023A8 Oxathiin carboxamide
06/08/2006	US20060122200 Use and application of a pharmaceutical composition containing a mixture of natural- origin heterocyclical guanidine, for cosmetology, wound healing, focal dystonia and muscular spasm- related clinical pathologies
06/08/2006	US20060121581 Production of bacterial strains cross reference to related applications
06/08/2006	US20060121519 Ligand and coordinating moiety for isolating preferential macromolecules in solution
06/07/2006	EP1666481A2 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine and the use thereof for the preparation of pyrrolo[2,3]pyrimidine derivatives as protein kinases inhibitors
06/07/2006	EP1663998A2 Process for the preparation of losartan potassium form i
06/07/2006	CN1784408A 8-substituted-6,7,8,9-tetrahy9dropyrimido (1,2-a) pyrimidin-4-one derivatives
06/07/2006	CN1784406A Purification and crystalline forms of zaleplon
06/07/2006	CN1784396A P38 inhibitors and methods of use thereof
06/07/2006	CN1784387A Benzimidazole derivatives
06/07/2006	CN1781918A Process for producing thioester compound
06/07/2006	CN1781915A Method for producing an oxazolylethanol derivative
06/07/2006	CN1781911A Intermediate for producing novel pyrazine derivatives
06/07/2006	CN1258530C Crystalline base of citalopram
06/06/2006	US7056946 antitumor taxane containing a carboante group at c-10 position, benzoyoxy at c-2 position and hydroxy at c-7 position in the ring (c3o-c6-c6-c8)
06/06/2006	CA2327723C Bicyclic hydroxamic acid derivatives
06/06/2006	CA2282585C Pyrazine compounds
06/01/2006	WO2006019353A9 Composition and method for the treatement of psoriasis
06/01/2006	US20060116399 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
06/01/2006	US20060116322 Formation of novel erythropoietin conjugates using transglutaminase
06/01/2006	US20060115533 Pharmaceutical compositions
05/2006
05/31/2006	EP1661887A1 Method for manufacture of sertindole
05/31/2006	EP1661564A1 Heterocyclic compounds and their pharmaceutical use
05/31/2006	EP1660460A1 Quinoxaline derivatives as neutrophil elastase inhibitors and their use
05/31/2006	EP1660456A2 Quaternary salt derivatives of 1,4-diphenylazetidin-2-ones
05/31/2006	EP1660446A2 Tethered dimers and trimers of 1,4-diphenylazetidn-2-ones
05/31/2006	EP1660444A2 Metal complexes of n-heterocyclic carbenes as radiopharmaceuticals and antibiotics
05/31/2006	EP1660442A2 Crystalline substance with tailored angle between surfaces
05/31/2006	EP1446122B1 Use of flibanserin in the treatment of sexual desire disorders
05/31/2006	EP1345922B1 Pyrazole compounds useful as protein kinase inhibitors
05/31/2006	CN1780835A Novel fused heterocycles and uses thereof.
05/31/2006	CN1257892C New indole derivatives with 5-HT6 receptor affinity
05/25/2006	US20060111577 Method for preparing 17 alpha-acetoxy-11beta-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, intermediates thereof, and methods for the preparation of such intermediates
05/25/2006	US20060111426 Indole-3-sulphur derivaties
05/25/2006	US20060111401 Taxanes having a C10 carbonate substituent
05/24/2006	EP1658366A2 Compositions of orthogonal glutamyl-trna and aminoacyl trna synthetase pairs and uses thereof
05/24/2006	EP1506185B1 Compounds and their use as inhibitors of 5-ht
05/24/2006	CN1777612A New piperidinylamino-thieno[2,3-d] pyrimidine compounds
05/24/2006	CN1257160C Aimoquinoline and aminopyridine derivatives and their use as adenosine A3 ligands
05/23/2006	US7049444 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
05/23/2006	US7049438 Quinazoline derivatives for treatment of tumours
05/23/2006	US7049321 Methods and pharmaceutical compositions for treatment of central and peripheral nervous system disorders and compounds useful therefor
05/23/2006	US7049312 2H-1,4-benzothiazin-3(4H)-one derivative as anticarcinogenic and antiproliferative agent; inhibitors of serine/threonine and tyrosine kinase activity
05/23/2006	US7049306 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4.
05/23/2006	CA2411766C Non-nucleoside reverse transcriptase inhibitors
05/23/2006	CA2291134C Method for the preparation of citalopram
05/18/2006	WO2006052190A1 Indazole sulphonamide derivatives
05/18/2006	WO2006052189A1 Nitro indazole derivatives
05/18/2006	WO2006051270A1 5-heteroaryl thiazoles and their use as p13k inhibitors

1 ... 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 ... 105